Wall--
I agree. Feuerstein is really not a careful reporter--he's more like a columnist--expressing his opinions and not always caring or analyzing carefully whether his opinions add up. Shoots from the hip. Reports his impressions. I was irritated by his statement that "The FDA examined Provenge's data and found it lacking". Talk about not being a reporter! That crystalizes the guy in a nutshell--ignore the politics at the FDA, ignore the mindless adherence to outdated endpoint purity, ignore the extra conflicts of interest revealed for Scher, ignore that the FDA truly pissed on its mandate to thoughtfully perform a cost/benefit analysis of Provenge with the idea in mind that terminal patients are desperate for treatment... I could go on, but you get the idea. He's typical of just about everyone at The Street.com--superficial lightweights flying by the seat of their pants. The only problem is those guys often move the market and are a factor in overall market perceptions. I don't usually do such a thing, but I sent him a reasoned email pointing out his sloppiness.
Market Data 
Markets 
AI
